The exception to this was cytochrome P450 1B1 (CYP1B1), which maintained on average greater than a sixfold difference between unaffected BMPR2 mutation carriers and carriers with PAH. The gene discussed is CYP1B1; the disease is pulmonary arterial hypertension.